Urodynamix Technologies Ltd. is a Vancouver based, publicly traded medical device company developing a portfolio of non-invasive diagnostic products for large and growing global healthcare markets. 

The Company develops medical devices based on near-infrared spectroscopy (NIRS) that aid in the diagnosis and treatment of urological conditions, intra-abdominal hypertension, erectile dysfunction and vascular diseases that affect over 200 million people worldwide.

Director, Corporate Development and Communications
Phone: (604) 638-0247
Fax: (604) 694-7771
Email: cpamplin@urodynamix.com

Registrars and Transfer Agents
Pacific Corporate Trust Company
625 Howe Street, 10th Floor
Vancouver, BC  V6C 3B8

Independent Auditors
Berris Mangan
1827 West 5th Avenue
Vancouver, BC  V6J 1P5

Forward-Looking Statements
Certain statements contained in this document constitute “forward-looking statements”. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “propose”, “anticipate”, “believe”, “forecast”, “estimate”, “expect” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the Company’s current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements.

Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not intend, and does not assume any obligation, to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments.